Hhr Asset Management, LLC Sangamo Therapeutics, Inc Transaction History

Hhr Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $1.13 Million - $1.77 Million	-103,810 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $331,818 - $653,571	-35,950 Reduced 25.72%	103,810 $1.62 Million
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $74,664 - $99,340	-7,960 Reduced 5.39%	139,760 $1.32 Million
Q2 2020 Aug 07, 2020	SELL	$6.21 - $11.83 $151,772 - $289,125	-24,440 Reduced 14.2%	147,720 $1.32 Million
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $138,116 - $201,240	-17,200 Reduced 9.08%	172,160 $1.44 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $1.66 Million - $2.47 Million	189,360 New	189,360 $2.04 Million

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $304M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhr Asset Management, LLC with notifications on news.